The emerging role of the PI3-K-Akt pathway in prostate cancer progression.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2005, v. 8, n. 2, p. 108, doi. 10.1038/sj.pcan.4500776
- By:
- Publication type:
- Article
Works matching IS 13657852 AND DT 2005 AND VI 8 AND IP 2
Results: 16
1
2
Effects of androgen suppression and radiation on prostate cancer suggest a role for angiogenesis blockade.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2005, v. 8, n. 2, p. 127, doi. 10.1038/sj.pcan.4500779
- By:
- Publication type:
- Article
3
Nerve-sparing radical retropubic prostatectomy: techniques and clinical considerations.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2005, v. 8, n. 2, p. 133, doi. 10.1038/sj.pcan.4500781
- By:
- Publication type:
- Article
4
PSA recurrence following radical prostatectomy is comparable for all age groups in the UK.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2005, v. 8, n. 2, p. 158, doi. 10.1038/sj.pcan.4500786
- By:
- Publication type:
- Article
5
Clinical ease of using doxazosin in BPH patients with and without hypertension.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2005, v. 8, n. 2, p. 152, doi. 10.1038/sj.pcan.4500787
- By:
- Publication type:
- Article
6
Long-term outcome of detectable PSA levels after radical prostatectomy.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2005, v. 8, n. 2, p. 163, doi. 10.1038/sj.pcan.4500788
- By:
- Publication type:
- Article
7
What is the best postoperative treatment for patients with pT3bN0M0 adenocarcinoma of the prostate?
- Published in:
- Prostate Cancer & Prostatic Diseases, 2005, v. 8, n. 2, p. 167, doi. 10.1038/sj.pcan.4500789
- By:
- Publication type:
- Article
8
In vitro inhibition of angiogenesis by prostasomes.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2005, v. 8, n. 2, p. 174, doi. 10.1038/sj.pcan.4500790
- By:
- Publication type:
- Article
9
Sociodemographic factors associated with postprostatectomy radiotherapy.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2005, v. 8, n. 2, p. 184, doi. 10.1038/sj.pcan.4500791
- By:
- Publication type:
- Article
10
The relationship between the androgen receptor CAG repeat polymorphism length and the response to intermittent androgen suppression therapy for advanced prostate cancer.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2005, v. 8, n. 2, p. 179, doi. 10.1038/sj.pcan.4500792
- By:
- Publication type:
- Article
11
Wnt signalling and prostate cancer.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2005, v. 8, n. 2, p. 119, doi. 10.1038/sj.pcan.4500794
- By:
- Publication type:
- Article
12
Bicalutamide (‘Casodex’) 150 mg in addition to standard care in patients with nonmetastatic prostate cancer: updated results from a randomised double-blind phase III study (median follow-up 5.1 y) in the early prostate cancer programme.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2005, v. 8, n. 2, p. 194, doi. 10.1038/sj.pcan.4500799
- By:
- Publication type:
- Article
13
Evaluating the use of early hormonal therapy in patients with localised or locally advanced prostate cancer.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2005, v. 8, n. 2, p. 140, doi. 10.1038/sj.pcan.4500800
- By:
- Publication type:
- Article
14
Prostate News.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2005, v. 8, n. 2, p. 104, doi. 10.1038/sj.pcan.4500804
- Publication type:
- Article
15
Report from London.
- Published in:
- 2005
- By:
- Publication type:
- Editorial
16
E-mail and oncology: a survey of radiation oncology patients and their attitudes to a new generation of health communication.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2005, v. 8, n. 2, p. 189, doi. 10.1038/sj.pcan.4500797
- By:
- Publication type:
- Article